Finoriq research workspace
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Institutional Holdings & 13F Ownership
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases. Review ARWR institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
- Company
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- Ticker
- ARWR
- Market Cap
- $10.1B
- Latest Price
- $71.69
- Industry
- Biotech & Pharma
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Top Institutional Holders
Top current 13F holders indexed for ARROWHEAD PHARMACEUTICALS, INC. (ARWR). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Ken FisherCIK 0000850529 | $69.8M | 0.02% | Filing2026-05-05 |
| 2 | Ray DalioCIK 0001350694 | $6M | 0.03% | Filing2026-05-15 |
| 3 | Joel GreenblattCIK 0001510387 | $2.4M | 0.01% | Filing2026-05-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.